Search Results - "Rigakos, Georgios"
-
1
BRCAness: Finding the Achilles Heel in Ovarian Cancer
Published in The oncologist (Dayton, Ohio) (01-07-2012)“…Ovarian cancer is the leading cause of death among gynecological cancers. It exhibits great heterogeneity in tumor biology and treatment response. Germline…”
Get full text
Journal Article -
2
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes
Published in Breast (Edinburgh) (01-02-2024)“…Dose-dense sequential (dds) chemotherapy has changed the clinical outcome of patients with early breast cancer (BC). To investigate the impact of dose…”
Get full text
Journal Article -
3
Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
Published in Translational oncology (01-02-2020)“…BACKGROUND: High grade glioma molecular profiling is of particular interest in neurooncology. The role of telomerase reverse transcriptase (TERT) varies…”
Get full text
Journal Article -
4
The Value of New Fields in the Medical Record for Quality Improvement
Published in Global journal on quality and safety in healthcare (Print) (01-05-2021)“…Quality in healthcare delivery is important for the safety and experience of patients with cancer. Effective documentation is an integral component of quality…”
Get full text
Journal Article -
5
Adverse effects of chemotherapy on the teeth and surrounding tissues of children with cancer: A systematic review with meta-analysis
Published in Oral oncology (01-08-2018)“…•Indications of dental adverse effects from chemotherapy for childhood cancer exist.•This systematic review summarizes dental and oral adverse effects of…”
Get full text
Journal Article -
6
BIOM-16. NTRK (NEUROTROPHIC TYROSINE RECEPTOR KINASE) FUSIONS IN GLIOMA PATIENTS: A PROMISING MOLECULAR TARGET?
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…Abstract BACKGROUND NTRK gene fusions are rare in gliomas (less than 2%). The use of TRK inhibitors in NTRK-fused solid tumors has generated significant…”
Get full text
Journal Article -
7
Clinical Presentation, Diagnosis, and Radiological Findings of Neoplastic Meningitis
Published in Cancer control (01-01-2017)“…Neoplastic meningitis is a complication of solid and hematological malignancies. It consists of the spread of malignant cells to the leptomeninges and…”
Get full text
Journal Article -
8
Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer
Published in Anticancer research (01-04-2021)“…Human epidermal growth factor receptor 2 (HER2) P95-isoform could be involved in trastuzumab resistance in HER2 metastatic breast cancer. A total of 114…”
Get full text
Journal Article -
9
Evaluation of the significance of TERT mutations in the presence of NF1 mutations in high grade glioma
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
10
Molecular profile and clinical features of patients with gliomas using a broad targeted next generation‑sequencing panel
Published in Oncology letters (01-01-2023)“…Gliomas are the most common malignant primary brain tumors characterized by poor prognosis. The genotyping of tumors using next generation sequencing (NGS)…”
Get full text
Journal Article -
11
MPTH-30ATRX CAN OCCUR IN IDH WILD-TYPE GBM
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2015)Get full text
Journal Article -
12
Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer
Published in Anticancer research (01-11-2018)“…Anti-resorptive drugs like bisphosphonates (BP) and denosumab are widely used for prevention and treatment of skeletal diseases, such as osteoporosis and bone…”
Get full text
Journal Article -
13
Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma
Published in Cancers (08-01-2021)“…Our aim was to determine the prevalence, prognostic and predictive role of germline pathogenic/likely pathogenic variants (P/LPVs) in cancer predisposing genes…”
Get full text
Journal Article -
14
New fields in the patient record: A tool or a nuisance?
Published in Journal of clinical oncology (01-03-2016)“…Abstract only 235 Background: The Contemporary Oncology Team was the first practice in Greece to participate in the Quality in Oncology Practice Initiative…”
Get full text
Journal Article -
15
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor
Published in Lung cancer (Auckland) (31-08-2021)“…Purpose: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred first-line option for patients with advanced, EGFR-mutant…”
Get full text
Journal Article -
16
Cancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report
Published in Molecular and clinical oncology (01-08-2016)“…Cancers of unknown primary (CUP) constitute a significant diagnostic and therapeutic challenge for clinicians and a frequent cause of cancer-related mortality…”
Get full text
Journal Article -
17
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece
Published in Lung cancer (Auckland) (01-01-2021)“…Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred first-line option for patients with advanced, EGFR-mutant non-small…”
Get full text
Journal Article -
18
Two cycles of carboplatin as adjuvant therapy in stage I seminoma: 8-year experience by the Hellenic Co-operative Oncology Group (HECOG)
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 4558 Background: Adjuvant chemotherapy is used in stage I testicular seminoma. We have reported a risk-adapted strategy of 2 cycles of…”
Get full text
Journal Article